Literature DB >> 12647014

Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl- L-cysteine-cDDP by TEA and PAH in the renal proximal tubule.

Robert J Kolb1, A Muhammad Ghazi, Delon W Barfuss.   

Abstract

PURPOSE: The objective of this study was to determine the effect of para-aminohippurate (PAH) and tetraethylammonium (TEA) on basolateral cellular accumulation (C(Pt)) and bath-to-lumen transepithelial transport rates (J(B)(-->)(L)) of platinum from cisplatin (cDDP) and a conjugate of cDDP, N-acetyl- L-cysteine-cDDP (NAC-cDDP), in S(1), S(2), and S(3) segments of the rabbit proximal tubule.
METHODS: Cellular accumulations and transport rates were determined using the isolated perfused tubule technique and samples were analyzed by ICP-MS.
RESULTS: First, to establish the control data, each tubular segment was bathed in free cDDP (2 m M) which resulted in no observable toxicity. Next, TEA (4 m M) was added to the bathing solution containing cDDP. This resulted in a reduction in platinum J(B)(-->)(L) by approximately 75% in the S(1) segment and 50% in the S(2) and S(3) segments. C(Pt) was reduced by 80-90% in relation to control values with no observable changes in toxicity. In the next experiment, exposure of the basolateral membrane to NAC-cDDP (2 m M) elicited pronounced toxicity after 20-30 min of perfusion. The J(B)(-->)(L) for NAC-cDDP was similar for each of the three nephron segments. There were no significant differences in the ability of these three segments to accumulate NAC-cDDP, but the conjugate increased uptake of platinum by 200-300% in the S(1) and S(2) segments, with no significant change in the S(3) segments, compared cDDP control values. The presence of PAH (4 m M) in the bathing solution significantly reduced J(B)(-->)(L) (by approximately 90%) for NAC-cDDP in all segments and the C(Pt) by approximately 80%. This also abrogated the NAC-cDDP-induced toxicity.
CONCLUSIONS: There was axial heterogeneity among the basolateral membranes of the S(1), S(2), and S(3) segments of the proximal tubule in accumulating free cDDP and transport of NAC-cDDP. Generally, the NAC-cDDP molecule was transported more avidly than free cDDP across the basolateral membrane, except in the S(3) segment, where accumulation was similar to that of free cDDP. It is concluded that a PAH-sensitive organic anion transporter is involved in the accumulation of NAC-cDDP at the basolateral membrane and a TEA-sensitive organic cation transport system is involved in the accumulation of free cDDP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12647014     DOI: 10.1007/s00280-002-0537-0

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  12 in total

1.  Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.

Authors:  Behnam Pedram; Ahmad Taghavi Moghadam; Zahra Kamyabi-Moghaddam; Omid Mavedati; Babak Abbas Beigi; Adel Khodaei Sharabiyani; Ali Bashiri Dezfuli; Soheil Khalili; Ali Mohammad Bahrami; Alireza Nasoori
Journal:  Tumour Biol       Date:  2015-01-17

2.  Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2.

Authors:  Giuliano Ciarimboli; Thomas Ludwig; Detlef Lang; Hermann Pavenstädt; Hermann Koepsell; Hans-Jürgen Piechota; Jörg Haier; Ulrich Jaehde; Jochen Zisowsky; Eberhard Schlatter
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 3.  Xenobiotic transporters and kidney injury.

Authors:  Blessy George; Dahea You; Melanie S Joy; Lauren M Aleksunes
Journal:  Adv Drug Deliv Rev       Date:  2017-01-20       Impact factor: 15.470

Review 4.  An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

Authors:  George J Dugbartey; Luke J Peppone; Inge A M de Graaf
Journal:  Toxicology       Date:  2016-10-04       Impact factor: 4.221

5.  The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.

Authors:  Navjotsingh Pabla; Robert F Murphy; Kebin Liu; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

6.  Cisplatin-induced renal injury is independently mediated by OCT2 and p53.

Authors:  Jason A Sprowl; Cynthia S Lancaster; Navjotsingh Pabla; Edwin Hermann; Ashley M Kosloske; Alice A Gibson; Lie Li; Dorothea Zeeh; Eberhard Schlatter; Laura J Janke; Giuliano Ciarimboli; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2014-06-10       Impact factor: 12.531

Review 7.  Mechanisms of Cisplatin nephrotoxicity.

Authors:  Ronald P Miller; Raghu K Tadagavadi; Ganesan Ramesh; William Brian Reeves
Journal:  Toxins (Basel)       Date:  2010-10-26       Impact factor: 4.546

8.  Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats.

Authors:  Nepton Soltani; Mehdi Nematbakhsh; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Farzaneh Ashrafi
Journal:  Nephrourol Mon       Date:  2013-08-20

Review 9.  Membrane transporters as mediators of Cisplatin effects and side effects.

Authors:  Giuliano Ciarimboli
Journal:  Scientifica (Cairo)       Date:  2012-11-25

10.  Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy.

Authors:  LeAnn C Rogers; Ryan R Davis; Naveen Said; Thomas Hollis; Larry W Daniel
Journal:  Redox Biol       Date:  2018-01-04       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.